Constraints and prospects in the management of pediatric HIV/AIDS

Edamisan O Temiye1, Adebola O Akinsulie, Chinyere V Ezeaka

  • 1Department of Paediatrics, College of Medicine of University of Lagos (CMUL), Nigeria. edatemiye2000@yahoo.co.uk

Insights

Pediatric HIV/AIDS cases increased in Nigeria, with most infants under 18 months presenting with severe symptoms. High drug costs limited access to antiretroviral therapy, impacting treatment outcomes.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Mother-to-child transmission is driving the rise in pediatric HIV/AIDS in Nigeria.
  • Limited diagnostic facilities and unaffordable therapies pose significant challenges.
  • The study investigated these factors at Lagos University Teaching Hospital (LUTH) from 1996 to 2002.

Purpose of the Study:

  • To examine the trends and characteristics of pediatric Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) cases.
  • To assess diagnostic methods, associated illnesses, and treatment outcomes.
  • To evaluate the socioeconomic and Human Immunodeficiency Virus (HIV) status of parents.

Main Methods:

  • Retrospective review of case records for pediatric HIV/AIDS patients.
  • Data collected included age, sex, diagnosis, comorbidities, treatment, and parental socioeconomic and HIV status.
  • Analysis focused on trends between 1996 and 2002.

Main Results:

  • 124 pediatric HIV/AIDS cases were identified, with 56.5% under 18 months and 89.5% showing multiple clinical features.
  • Diagnosis relied on clinical criteria, with limited use of Polymerase Chain Reaction (PCR) or CD4+ counts.
  • Tuberculosis was the most common co-infection (25.8%), and only 20.2% received antiretroviral drugs; mothers were more frequently HIV-positive than fathers.

Conclusions:

  • Pediatric HIV/AIDS is increasing at LUTH, with higher maternal HIV infection rates.
  • Prohibitive drug costs severely restricted access to essential antiretroviral therapy.
  • High rates of discharge against medical advice and follow-up default were observed.
Abstract

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...